The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
Practice Corner FAQ’s Q: Is there a maximum number for allergen tests? A: For an…
from CRD Associates Election Update Donald Trump won the presidency with 312 electoral votes, with…
On November 1, the Centers for Medicare & Medicaid Services (CMS) released the Medicare Physician…
12/01/24: Research Grant Cycle
Learn more
06/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
You can now access 19.5 hrs of CME | Continuing Certification (CC) until May 30 by watching recorded content from the AAOA Explorers Course 2025!
Live from the Explorers Course
Live Update from the Course
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
Access 19.5 hrs of Recorded Content
Until May 30
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Learn More and Register
Explorers Course 2026:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
January 22-24, 2026
Fairmont Sonoma Mission Inn & Spa,
Sonoma, CA
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
Haidy Marzouk, MD, FAAOA, and Christopher Vickery, MD, FAAOA, members of the AAOA Patient &…
Practice Corner FAQ’s https://youtu.be/F7rlAIK27bc We receive regular questions about when to use modifiers. The video…
“Don’t follow the crowd, let the crowd follow you” — Margret Thatcher This morning I…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
President Biden’s State of the Union Address State of the Union Transcript State of the Union Video Post-State of the Union White House Briefings The Biden-Harris Administration's Economic Agenda FEATURING: Secretary Pete Buttigieg, U.S. Department of Transportation and Senior Administration Officials WHEN:…
AMA Advocacy Update The House of Representatives voted 339-85 on March 6 to pass the first tranche of spending bills for fiscal year 2024, along with the attached “skinny” package of health care provisions. The Senate is expected to pass…
The Centers for Medicare & Medicaid Services recently sent a memo to Medicare Advantage (MA) organizations and Medicare-Medicaid plans that provides additional information on the coverage criteria for basic benefits, the use of prior authorization, and review of utilization management…
Please take the time to complete the Physician Practice Information Survey! If you or your practice manager receive the survey, make sure to complete it. The information you provide will be extremely valuable in updating payment rates for the services…
Impacting allergy immunotherapy vial preparation, USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations went into effect November 1st. With this comes opportunities to review and refine your allergy vial prep processes and protocols. AAOA has developed tools and resources to…
On November 1, 2023, the new chapter of USP General Chapter <797> was implemented. AAOA has resources and tools to help you meet the <797> compliance requirements. Check out the video on USP General Chapter <797> Sterile Allergen Extract Compounding, AAOA…
November 1, 2023 is the implementation date for the new chapter. AAOA has resources and tools to help you meet the <797> compliance requirements. Online Sterile Allergen Extract Compounding Module Special AAOA member pricing for Valiteq Media Fill Test kits…
The American Medical Association (AMA) is undertaking a new national study, supported by 173 healthcare organizations, to collect representative data on physician practice expenses. The aim of the Physician Practice Information Survey is to better understand the costs faced by today’s…
United Healthcare has recently announced a policy change. Effective January 1, 2023, UHC will no longer cover home- and self-administered subcutaneous allergen immunotherapy. The AAOA, in conjunction with AAOHNS, is working to try to reverse this policy change. In the meantime,…
After a multi-year effort, the long-awaited revision of Chapter 797 Standards for Sterile Compounding (797) of the United States Pharmacopeia (USP) has been released with an expected implementation date of November 1, 2023. Thanks to the joint efforts of the AAOA,…